Abstract
Oncologic emergencies can threaten the lives of children with cancer even before a diagnosis is made. Awareness of common or life-threatening toxicities of cancer and cancer treatment facilitates rapid diagnosis and appropriate immediate management. Clinicians in both primary and tertiary care must recognize and manage five types of oncologic emergency: masses affecting vital organs (superior vena cava [SVC] syndrome, central airway compression [CAC] syndrome, cardiac tamponade, pleural effusion, spinal cord compression, and intracranial hypertension), metabolic emergencies (tumor lysis syndrome [TLS], hypercalcemia, hyponatremia, lactic acidosis, adrenal insufficiency), gastrointestinal emergencies (typhlitis, intestinal obstruction, bowel perforation), and chemotherapy extravasation. For new patients with suspected cancer, a careful history to elicit signs and symptoms, a physical examination, chemistry profile, complete blood count, and chest radiograph are sufficient to rule out an oncologic emergency. Any neurologic deficit, respiratory distress, altered vital signs, abdominal tenderness, abnormal laboratory values, or mediastinal mass on chest radiograph should prompt a thorough and immediate evaluation for life- and organ-threatening emergencies, which are the subject of this chapter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
McCurdy MT, Shanholtz CB. Oncologic emergencies. Crit Care Med. 2012;40(7):2212–22.
Baldwin KJ, Zivkovic SA, Lieberman FS. Neurologic emergencies in patients who have cancer: diagnosis and management. Neurol Clin. 2012;30(1):101–28; viii.
Demshar R, Vanek R, Mazanec P. Oncologic emergencies: new decade, new perspectives. AACN Adv Crit Care. 2011;22(4):337–48.
Rachapalli V, Boucher LM. Superior Vena cava syndrome:role of the interventionalist. Can Assoc Radiol J . 2013 Feb 14. pii: S0846–5371(12)00108-8. doi: 10.1016/j.carj.2012.09.003.
Chaudhary K, Gupta A, Wadhawan S, Jain D, Bhadoria P. Anesthetic management of superior vena cava syndrome due to anterior mediastinal mass. J Anaesthesiol Clin Pharmacol. 2012;28(2):242–6.
Cheng S. Superior vena cava syndrome: a contemporary review of a historic disease. Cardiol Rev. 2009;17(1):16–23.
Wan JF, Bezjak A. Superior vena cava syndrome. Emerg Med Clin North Am. 2009;27(2):243–55.
Spottswood SE, Goble MM, Massey GV, Ben-Ezra JM. Acute monoblastic leukemia presenting with pericardial effusion and cardiac tamponade. Pediatr Radiol. 1994;24(7):494–5.
da Costa CM, de Camargo B, Lamelas R, et al. Cardiac tamponade complicating hyperleukocytosis in a child with leukemia. Med Pediatr Oncol. 1999;33(2):120–3.
Kaifi JT, Toth JW, Gusani NJ, et al. Multidisciplinary management of malignant pleural effusion. J Surg Oncol. 2012;105(7):731–8.
Muzumdar H. Pleural effusion. Pediatr Rev. 2012;33(1):45–7.
McGrath EE, Anderson PB. Diagnosis of pleural effusion: a systematic approach. Am J Crit Care. 2011;20(2):119–27.
Wide JM, Curtis J. Granulocytic sarcoma as a cause of cord compression. Clin Radiol. 1997;52(10):803.
Bartek Jr J, Abedi-Valugerdi G, Liska J, Nystrom H, Andresen M, Mathiesen T. Intracranial hemorrhage due to intracranial hypertension caused by the superior vena cava syndrome. J Clin Neurosci. 2013;20:1040–1.
Labrador J, Puig N, Ortin A, Gutierrez NC, Gonzalez-Diaz M. Multiple cranial neuropathy and intracranial hypertension associated with all-trans retinoic acid treatment in a young adult patient with acute promyelocytic leukemia. Int J Hematol. 2012;96(3):383–5.
Vartzelis G, Lancaster D, Fallon P. Intracranial hypertension in pediatric patients with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2009;52(3):418–20.
Legrand F, Dorgeret S, Saizou C, Duval M, Vilmer E. Cerebellar herniation after intrathecal chemotherapy including cytosine arabinoside in a boy with T acute lymphoblastic leukemia. Leukemia. 2002;16(12):2454–5.
Fink ME. Osmotherapy for intracranial hypertension: mannitol versus hypertonic saline. Continuum (Minneap Minn). 2012;18(3):640–54.
Mercille G, Ospina LH. Pediatric idiopathic intracranial hypertension: a review. Pediatr Rev. 2007;28(11):e77–86.
Howard SC, Jones DP, Pui CH. The tumor lysis syndrome. N Engl J Med. 2011;364(19):1844–54.
Cairo MS, Coiffier B, Reiter A, Younes A. Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus. Br J Haematol. 2010;149(4):578–86.
Coiffier B, Altman A, Pui CH, Younes A, Cairo MS. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. J Clin Oncol. 2008;26(16):2767–78.
McKay C, Furman WL. Hypercalcemia complicating childhood malignancies. Cancer. 1993;72(1):256–60.
Kerdudo C, Aerts I, Fattet S, et al. Hypercalcemia and childhood cancer: a 7-year experience. J Pediatr Hematol Oncol. 2005;27(1):23–7.
Andiran N, Alikasifoglu A, Kupeli S, Yetgin S. Use of bisphosphonates for resistant hypercalcemia in children with acute lymphoblastic leukemia: report of two cases and review of the literature. Turk J Pediatr. 2006;48(3):248–52.
Gokce M, Unal S, Gulsen H, et al. A rare metabolic complication of acute lymphoblastic leukemia in childhood: lactic acidosis. Turk J Pediatr. 2012;54(1):61–3.
Sillos EM, Shenep JL, Burghen GA, Pui CH, Behm FG, Sandlund JT. Lactic acidosis: a metabolic complication of hematologic malignancies: case report and review of the literature. Cancer. 2001;92(9):2237–46.
Howard SC, Pui CH. Endocrine complications in pediatric patients with acute lymphoblastic leukemia. Blood Rev. 2002;16(4):225–43.
Krutisch G, Valentin A. Comatose state due to severe hyponatremia in a patient with the syndrome of inappropriate antidiuretic hormone secretion. Intensive Care Med. 2001;27(5):944.
Haycock GB. The syndrome of inappropriate secretion of antidiuretic hormone. Pediatr Nephrol. 1995;9(3):375–81.
Moritz ML, Ayus JC. New aspects in the pathogenesis, prevention, and treatment of hyponatremic encephalopathy in children. Pediatr Nephrol. 2010;25(7):1225–38.
Moritz ML, Ayus JC. 100 cc 3% sodium chloride bolus: a novel treatment for hyponatremic encephalopathy. Metab Brain Dis. 2010;25(1):91–6.
Omari A, Kormas N, Field M. Delayed onset of central pontine myelinolysis despite appropriate correction of hyponatraemia. Intern Med J. 2002;32(5–6):273–4.
Felner EI, Thompson MT, Ratliff AF, White PC, Dickson BA. Time course of recovery of adrenal function in children treated for leukemia. J Pediatr. 2000;137(1):21–4.
Krasner AS. Glucocorticoid-induced adrenal insufficiency. JAMA. 1999;282(7):671–6.
August GP. Treatment of adrenocortical insufficiency. Pediatr Rev. 1997;18(2):59–62.
Cooper MS, Stewart PM. Corticosteroid insufficiency in acutely ill patients. N Engl J Med. 2003;348(8):727–34.
Leman P. Addison’s disease. Hydrocortisone should be started immediately adrenal insufficiency is considered. BMJ. 1996;313(7054):427.
Altinel E, Yarali N, Isik P, Bay A, Kara A, Tunc B. Typhlitis in acute childhood leukemia. Med Princ Pract. 2012;21(1):36–9.
Moran H, Yaniv I, Ashkenazi S, Schwartz M, Fisher S, Levy I. Risk factors for typhlitis in pediatric patients with cancer. J Pediatr Hematol Oncol. 2009;31(9):630–4.
Mullassery D, Bader A, Battersby AJ, et al. Diagnosis, incidence, and outcomes of suspected typhlitis in oncology patients–experience in a tertiary pediatric surgical center in the United Kingdom. J Pediatr Surg. 2009;44(2):381–5.
Alexander JE, Williamson SL, Seibert JJ, Golladay ES, Jimenez JF. The ultrasonographic diagnosis of typhlitis (neutropenic colitis). Pediatr Radiol. 1988;18(3):200–4.
Junpaparp P, Buppajarntham S, Madueno FV, Varadi G. Concomitant typhlitis and Clostridium difficile colitis developed after first R-CHOP chemotherapy in a non-Hodgkin lymphoma patient. BMJ Case Rep. 2013 Apr 17;2013. doi:pii: bcr2013008894. 10.1136/bcr-2013-008894.
Haase R, Merkel N, Diwan O, Elsner K, Kramm CM. Leukapheresis and exchange transfusion in children with acute leukemia and hyperleukocytosis. A single center experience. Klin Padiatr. 2009;221(6):374–8.
Krance RA, Hurwitz CA, Head DR, et al. Experience with 2-chlorodeoxyadenosine in previously untreated children with newly diagnosed acute myeloid leukemia and myelodysplastic diseases. J Clin Oncol. 2001;19(11):2804–11.
Porcu P, Cripe LD, Ng EW, et al. Hyperleukocytic leukemias and leukostasis: a review of pathophysiology, clinical presentation and management. Leuk Lymphoma. 2000;39(1–2):1–18.
Lichtman MA, Heal J, Rowe JM. Hyperleukocytic leukaemia: rheological and clinical features and management. Baillieres Clin Haematol. 1987;1(3):725–46.
Polak R, Huisman A, Sikma MA, Kersting S. Spurious hypokalaemia and hypophosphataemia due to extreme hyperleukocytosis in a patient with a haematological malignancy. Ann Clin Biochem. 2010;47(Pt. 2):179–81.
Lowe EJ, Pui CH, Hancock ML, Geiger TL, Khan RB, Sandlund JT. Early complications in children with acute lymphoblastic leukemia presenting with hyperleukocytosis. Pediatr Blood Cancer. 2005;45(1):10–5.
Ozdemir MA, Karakukcu M, Patiroglu T, Torun YA, Kose M. Management of hyperleukocytosis and prevention of tumor lysis syndrome with low-dose prednisone continuous infusion in children with acute lymphoblastic leukemia. Acta Haematol. 2009;121(1):56–62.
Cull LF, Nolan MB. Treating neutropenic fever in the emergency department: delays may be deadly! J Emerg Nurs. 2009;35(1):36–9.
Goldberg E, Gafter-Gvili A, Robenshtok E, Leibovici L, Paul M. Empirical antifungal therapy for patients with neutropenia and persistent fever: systematic review and meta-analysis. Eur J Cancer. 2008;44(15):2192–203.
Binz P, Bodmer N, Leibundgut K, Teuffel O, Niggli FK, Ammann RA. Different fever definitions and the rate of fever and neutropenia diagnosed in children with cancer: a retrospective two-center cohort study. Pediatr Blood Cancer. 2013;60(5):799–805.
Gavidia R, Fuentes SL, Vasquez R, et al. Low socioeconomic status is associated with prolonged times to assessment and treatment, sepsis and infectious death in pediatric fever in El Salvador. PLoS One. 2012;7(8):e43639.
Tallman M, Douer D, Gore S, et al. Treatment of patients with acute promyelocytic leukemia: a consensus statement on risk-adapted approaches to therapy. Clin Lymphoma Myeloma Leuk. 2010;10:S122–6.
Tallman MS. Updates on the treatment of acute promyelocytic leukemia. Clin Adv Hematol Oncol. 2010;8(2):89–90.
Green D. Management of bleeding complications of hematologic malignancies. Semin Thromb Hemost. 2007;33(4):427–34.
Agrawal AK, Hsu E, Quirolo K, Neumayr LD, Flori HR. Red blood cell transfusion in pediatric patients with severe chronic anemia: how slow is necessary? Pediatr Blood Cancer. 2012;58(3):466–8.
Weiskopf RB. Emergency transfusion for acute severe anemia: a calculated risk. Anesth Analg. 2010;111(5):1088–92.
Perez Fidalgo JA, Garcia FL, Cervantes A, Margulies A, Vidall C, Roila F. Management of chemotherapy extravasation: ESMO–EONS clinical practice guidelines. Eur J Oncol Nurs. 2012;16(5):528–34.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Chitsike, I., Howard, S.C. (2014). Oncologic Emergencies. In: Stefan, D., Rodriguez-Galindo, C. (eds) Pediatric Hematology-Oncology in Countries with Limited Resources. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-3891-5_9
Download citation
DOI: https://doi.org/10.1007/978-1-4614-3891-5_9
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-3890-8
Online ISBN: 978-1-4614-3891-5
eBook Packages: MedicineMedicine (R0)